Better results through less stress
Researchers in Hannover have developed a new method for studying neuroinfections. This reduces errors in analysis and delivers more accurate results.
Read more
Infection research at the interface between clinical practice and basic research
At TWINCORE, we combine the expertise of medical professionals and scientists from a wide range of disciplines to find answers to the pressing questions in infection research. Our focus: translational research – the bridge between basic science and clinical application.
Apply for LISA 2025
Registration for the Lower Saxony International Summer Academy 2025 is open until 2025.
Find more information here!
New approaches to research into systemic sclerosis
A research team at TWINCORE was able to establish that TLR8 influences the formation of disease-relevant cytokines.
Read more
More than the sum of the parts
TWINCORE researchers show role of epistatic interaction in the omicron variant of SARS-CoV-2 virus .
Read moreResearch
We conduct translational infection research to improve the prevention, diagnosis and treatment of infectious diseases in humans. We focus on three areas that characterize our research work. Find out here how we proceed and what results we achieve.
Immunology
Virology
Bacteriology
Labs at TWINCORE
Under the leadership of our best scientists, various labs are working on different projects within our research topics.
2025Chemistry (Weinheim an der Bergstrasse, Germany)31 (4) : e202403390
Dynamic Combinatorial Chemistry Unveils Nsp10 Inhibitors with Antiviral Potential Against SARS-CoV-2
Jumde R, Jézéquel G, Saramago M, Frank N, Adam S, Cunha M, Bader C, Gunesch A, Köhler N, Johannsen S, Bousis S, Pietschmann T, Matos R, Müller R, Arraiano C, Hirsch A
2025International journal of cancer156 (2) : 339-352
Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional characterization
Gálvez-Montosa F, Peduzzi G, Sanchez-Maldonado J, Ter Horst R, Cabrera-Serrano A, Gentiluomo M, Macauda A, Luque N, Ünal P, García-Verdejo F, Li Y, López López J, Stein A, Bueno-de-Mesquita H, Arcidiacono P, Zanette D, Kahlert C, Perri F, Soucek P, Talar-Wojnarowska R, Theodoropoulos G, Izbicki J, Tamás H, Van Laarhoven H, Nappo G, Petrone M, Lovecek M, Vermeulen R, Adamonis K, Reyes-Zurita F, Holleczek B, Sumskiene J, Mohelníková-Duchoňová B, Lawlor R, Pezzilli R, Aoki M, Pasquali C, Petrenkiene V, Basso D, Bunduc S, Comandatore A, Brenner H, Ermini S, Vanella G, Goetz M, Archibugi L, Lucchesi M, Uzunoglu F, Busch O, Milanetto A, Puzzono M, Kupcinskas J, Morelli L, Sperti C, Carrara S, Capurso G, van Eijck C, Oliverius M, Roth S, Tavano F, Kaaks R, Szentesi A, Vodickova L, Luchini C, Schöttker B, Landi S, Dohan O, Tacelli M, Greenhalf W, Gazouli M, Neoptolemos J, Cavestro G, Boggi U, Latiano A, Hegyi P, Ginocchi L, Netea M, Sánchez-Rovira P, Canzian F, Campa D, Sainz J
2025Protein science : a publication of the Protein Society34 (1) : e5251
A novel method for recombinant mammalian-expressed S-HBsAg virus-like particle production for assembly status analysis and improved anti-HBs serology
Lehky M, Moonian T, Michel T, Junker D, Müsken M, Strömpl J, Nübling P, Neumann F, Krumbholz A, Krause G, Schneiderhan-Marra N, van den Heuvel J, Strengert M
Graalmann Lab
Immunology
Tissue inflammation upon chronic rheumatic diseases
Patients with chronic rheumatic diseases have an increased risk of infection due to severe inflammation. This project investigates inflammation in various tissues, particularly in systemic sclerosis, in order to develop targeted therapies.
Graalmann Lab
Immunology
Indirect effects of immunomodulatory drugs
Immunomodulatory drugs for rheumatic diseases specifically influence immune cells and messenger substances. This project investigates their effect on immune responses in order to find individually suitable therapies.
Graalmann Lab
Immunology
Cell-selective targeting of immune cells
Immunomodulatory drugs can have systemic side effects. This project is testing nanocarriers that deliver drugs specifically into myeloid immune cells in order to reduce side effects and increase the local effect.
Kalinke Lab
Immunology
Immunological sensing of cytomegalovirus (CMV)
The project investigates how HCMV is recognized by the immune system and which mechanisms the virus uses to camouflage itself. The aim is to understand the immune reactions and develop therapies for severely affected patients.
Career at TWINCORE
Want to become part of TWINCORE?
Take a look at our job advertisements to see if there is something suitable for you or send us an unsolicited application.
